Back to Allianz Asset Management GmbH Allianz Asset Management GmbH

CORTCORT

Showing 8 of 21 quarters

Position history for Allianz Asset Management GmbHAllianz Asset Management GmbH's holdings in Corcept Therapeutics Incorporated

Yes. Allianz Asset Management holds 89,152 shares of CORT (Corcept Therapeutics), worth $7.8M, as of its Q2 2026 13F filing. The share count is unchanged from Q1 2026. Allianz Asset Management has held CORT since Q4 2022, across 15 quarterly 13F filings.

Current Value

$7.8M

Current Shares

89,152

Total Value Change

+$513,574

Total Shares Change

-67,248

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Unchanged
89,152
0.0%
$7.8M0.0%$86.95
0
2026-Q1
Decreased
89,152
-0.8%
$3.6M0.0%$40.31
0
2025-Q4
Decreased
89,905
-41.4%
$3.1M0.0%$34.80
0
2025-Q3
Increased
153,396
+0.1%
$12.7M0.0%$83.11
28
2025-Q2
Decreased
153,292
-5.5%
$11.3M0.0%$73.40
0
2025-Q1
Decreased
162,194
-0.6%
$18.5M0.0%$114.22
0
2024-Q4
Increased
163,100
+4.3%
$8.2M0.0%$50.39
29
2024-Q3
Decreased
156,400
-13.9%
$7.2M0.0%$46.28
0

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used